Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease

Burbulla, Lena F., Song, Pingping, Mazzulli, Joseph R., Zampese, Enrico, Wong, Yvette C., Jeon, Sohee, Santos, David P., Blanz, Judith +8 more·2017·Science

DOI 10.1126/science.aam9080

Cited by (875)

Items 601–700 of 875

Golgi apparatus-targeted BODIPY-based photosensitizer synergized with glutaminase inhibition for enhanced photodynamic therapy
Jiawei Li, Qiqi Yu, Yang Li, Dongdong Xu, Shouchun Yin · 2024 · Dyes and Pigments
New insights into axonal regulators of dopamine transmission in health and disease
Kathryn L. Todd, Kaitlyn M. L. Cramb, Katherine R. Brimblecombe, Stephanie Jane Cragg · 2025 · Current Opinion in Neurobiology
Enhanced activity of superoxide dismutase is a common response to dietary and genetically induced increased cholesterol levels
Kristina Dominko, Domagoj Đikić, Silva Katusic Hecimovic · 2018 · Nutritional Neuroscience
Calcium Channels and Selective Neuronal Vulnerability in Parkinson’s Disease
Birgit Liss, Dalton James Surmeier · 2022 · Springer eBooks
A chemical probe unravels the reactive proteome of health-associated catechols
Angela Weigert Muñoz, Kevin M. Meighen-Berger, Stephan M. Hacker, Matthias Johannes Feige, Stephan A. Sieber · 2023 · Chemical Science
CAP2 contributes to Parkinson’s disease diagnosed by neutrophil extracellular trap-related immune activity
Xiaohe Li, Meiling Luo, Hangrui Xu, Lei Jia, Yanan Liang, Qianxi Xu, Yonghui Wang · 2024 · Frontiers in Immunology
Calcineurin-mediated regulation of growth-associated protein 43 is essential for neurite and synapse formation and protects against α-synuclein-induced degeneration
Ekaterina A. Grebenik, Sofia Zaichick, Gabriela Caraveo · 2025 · Frontiers in Aging Neuroscience
How Sensors, Devices, and Biomarkers Can Transform Precision Medicine: Perspectives From a Clinical and Translational Science Institute
Jill L. Maron, Graham B. Jones · 2018 · Clinical Therapeutics
Pathogenetic insights into young-onset Parkinson disease
Anthony H.V. Schapira, Huw R. Morris · 2020 · Nature Reviews Neurology
Solvent-dependent tautomeric equilibrium between fluorescent colorimetric probes with dual mitochondrial/liposome targetability
Chenchen Yang, Jinshuai Song, Ying Ding, Haohui Ren, Mingming Yu, Hongyan Zhang, Zhanxian Li · 2021 · Dyes and Pigments
Repeat expansion disorders
Sharan R. Srinivasan, Claudio Melo de Gusmão, Joanna A. Korecka, Vikram Khurana · 2022 · Elsevier eBooks
Targeting PARK7 Improves Acetaminophen-Induced Acute Liver Injury by Orchestrating Mitochondrial Quality Control and Metabolic Reprogramming
Jiao Cai, Deqin Kong, Zi Long, Jiangzheng Liu, Rui Liu, Chunxu Hai · 2022 · Antioxidants
Harnessing the Digital Exhaust: Incorporating Wellness into the Pharma Model
Justin M. Wright, Graham B. Jones · 2018 · Digital Biomarkers
Superoxide Dismutases SOD1 and SOD2 Rescue the Toxic Effect of Dopamine-Derived Products in Human SH-SY5Y Neuroblastoma Cells
Alice Biosa, Federica De Lazzari, Anna Masato, Roberta Filograna, Nicoletta Plotegher, Mariano Beltramini, Luigi Bubacco, Marco Bisaglia · 2019 · Neurotoxicity Research
SpaMTP: Integrative Statistical Analysis and Visualisation of Spatial Metabolomics and Transcriptomics data
Andrew Causer, Tianyao Lu, Christopher C. J. Fitzgerald, Andrew Newman, Hani Vu, Xiao Tan, Tuan Vo, Cedric S. Cui, Vinod K. Narayana, James Richard Whittle et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Interorganelle phospholipid communication, a house not so divided
Richard G. Lee, Danielle L. Rudler, Oliver Rackham, Aleksandra Filipovska · 2024 · Trends in Endocrinology and Metabolism
Oxidative stress in neurodegeneration: in vitro models for investigating cellular damage and neuroprotective strategies
Alime Garip, Denitsa Stefanova, Virginia Tzankova · 2025 · Pharmacia
Dysregulated circRNA–miRNA–mRNA networks reveal stage-specific mRNA expression changes in Parkinson’s disease
Yulan Gao, Konii Takenaka, Kristina Santucci, Grace Lindner, Si-Mei Xu, Yuning Cheng, Michael Janitz · 2025 · Molecular Brain
The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives
Gabriela Mantovani Baldasso, Rodrigo Sebben Paes, A. F. Moreira, Sofia Gallo Salvadori, Christian Limberger, Fiorentina Roviezzo, Raffaele Capasso, Rafael Cypriano Dutra · 2026 · Pharmacological Research
When Pathways Converge: Iron, Lipid Peroxidation, and α‐Synuclein in Ferroptosis‐Driven Dopaminergic Neurodegeneration
Carmem Lúcia Sperlich, Brent R. Stockwell, Marcelo Farina · 2026 · Journal of Neurochemistry
Nanosensor-based imaging of realtime dopamine release in neurons derived from iPSCs of patients with Parkinson's disease
Nayeon Lee, Dakyeon Lee, Jae Hyeok Lee, Bo Seok Lee, Sungjee Kim, Jae Ho Kim, Sanghwa Jeong · 2025 · Materials Today Bio
Pyridoxal phosphate inhibits alpha-synuclein-induced ferroptosis by activating GOT1 to enhance the methionine salvage pathway in Parkinson's disease
Xudong Min, Zhuolin Du, Jirui Wei, Zhao Yuan, Yang She, Xiayu Jin, Zhixiong Su, Hengxu Mao, Jing Cai, Zhiyuan Zhu et al. · 2025 · Experimental Neurology
Disease mechanisms as Subtypes: Mitochondrial and bioenergetic dysfunction
Patricia González‐Rodríguez, Enrico Zampese, Dalton James Surmeier · 2023 · Handbook of clinical neurology
Recent insights into the control of mitochondrial fission
Jiajia He, Ke Liu, Chuanhai Fu · 2024 · Biochemical Society Transactions
The Interplay of Mitochondrial Bioenergetics and Dopamine Agonists as an Effective Disease-Modifying Therapy for Parkinson’s Disease
Neha Neha, Iqra Mazahir, Sara Akhtar Khan, Pooja Kaushik, Suhel Parvez · 2024 · Molecular Neurobiology
Tetramethylpyrazine Nitrone Promotes the Clearance of Alpha-Synuclein via Nrf2-Mediated Ubiquitin–Proteasome System Activation
Baojian Guo, Chengyou Zheng, Jie Cao, Xiaoling Qiu, Fangcheng Luo, Haitao Li, Simon Ming‐Yuen Lee, Xifei Yang, Gaoxiao Zhang, Yewei Sun et al. · 2024 · NeuroMolecular Medicine
The Role of Structural Variants in the Genetic Architecture of Parkinson’s Disease
Abigail Miano‐Burkhardt, Pilar Álvarez Jerez, Kensuke Daida, Sara Bandrés‐Ciga, Kimberley J. Billingsley · 2024 · International Journal of Molecular Sciences
Rethinking Parkinson's disease: could dopamine reduction therapy have clinical utility?
Jonathan Sackner‐Bernstein · 2024 · Journal of Neurology
A2-Astrocyte Activation by Short-Term Hypoxia Rescues α-Synuclein Pre-Formed-Fibril-Induced Neuronal Cell Death
Ha Nyeoung Choi, Seon‐Hee Kim, Min Gi Jo, Bina Lee, Young Jin Kim, So Eun Lee, Jeong Hyun Lee, Hyemin Seong, Seong-Jae Kim, Sang Won Park et al. · 2025 · Biomedicines
Direct At-Sea Observations of Elephant Seals (Mirounga spp.) to Help Interpret Digital Bio-logging Data
John van den Hoff, Sam Thalmann · 2020 · The Open Biology Journal
Possibilities of Combinatorial Therapy: Insulin Dysregulation and the Growth Hormone Perspective on Neurodegeneration
Priyanka Sengupta, Debashis Mukhopadhyay · 2021 · IntechOpen eBooks
Monoamine Oxidase Inhibitor (MAO-I)-Mediated Neuroprotection for Treating Parkinson’s Disease
Toshiharu Nagatsu, Akira Nakashima · 2020 · Springer eBooks
Cytosolic dopamine determines hypersensitivity to blunt force trauma
Kielen R. Zuurbier, Rene Solano Fonseca, Sonja L. B. Arneaud, Lexus Tatge, Gupse Otuzoglu, Jordan M. Wall, Peter M. Douglas · 2024 · iScience
Grundlagen und Stellenwert der COMT- und MAO-B-Inhibitoren in der Therapie des idiopathischen Parkinson-Syndroms
Dirk Woitalla, Rejko Krüger, Stefan Lorenzl, Thomas H. Müller, Guenther Oelwein, Alexander Storch, Martin Wolz, Ullrich Wüllner · 2020 · Fortschritte der Neurologie · Psychiatrie
Organelle Interaction and Drug Discovery: Towards Correlative Nanoscopy and Molecular Dynamics Simulation
Zhiwei Yang, Zichen Zhang, Yizhen Zhao, Qiushi Ye, Xuhua Li, Lingjie Meng, Jiangang Long, Shengli Zhang, Lei Zhang · 2022 · Frontiers in Pharmacology
Engineered Cerebral Organoids Recapitulate Adult Tau Expression and Disease-relevant Changes in Tau Splicing
Christopher Edward James Lovejoy, Argyro Alatza, Charles Arber, Grant Galasso, Teisha Y. Bradshaw, An Verheyen, Tammaryn Lashley, Tamás Révész, John Hardy, Celeste M M. Karch et al. · 2020
Metabolomics: Potential non-protein biomarker candidates of Parkinson's disease
Michal Kaleta, Gabriel González, Eva Hényková, Kateřina Menšíková, Dorota Koníčková, Petr Kaňovský · 2025 · Neuroscience & Biobehavioral Reviews
Flexible and Stretchable Gold Three-Dimensional Electrode: Neural Network Induction and Mechanotransduction Observation
Jialu Wang, Xiaofan Xu, Meihong Peng, Yongqi Bao, Jing Dai, Zhiqiang Zhao, Kai Li, Chaoyue Gu, Yuqing Lin · 2025 · ACS Sensors
The role of mitochondrial genetics in Parkinson’s disease: Long-read sequencing as an emerging method
Ngan Le Kim Tran, Marka van Blitterswijk, Wolfdieter Springer, Pamela J. McLean, E. G. Martinez Peña, Rodolfo Savica, Owen A. Ross · 2025 · Med
LRRK2 and the fragile synapse: a molecular prelude to Parkinson’s disease?
Beatrice Masotti, Giulia Tombesi, Loukia Parisiadou, Elisa Greggio · 2025 · Biochemical Journal
ALDH2 protects against dopaminergic neuronal cell ferroptosis by enhancing the enzyme activity of PRDX6 in Parkinson’s disease
Xuan Li, Sijia Peng, Yu Wang, Xin Chen, Tingting Wu, Ya Feng, Xixi Wang, Huiyong Yin, Yun‐Cheng Wu · 2025 · npj Parkinson s Disease
Cerebrospinal fluid dopamine 3-O-sulfate as a novel biomarker for predicting motor complications in Parkinson’s disease: insights from the PPMI cohort
Jieshan Chi, Rui Yang, Piao Zhang, Siming Rong, Mengfei Cai, Yuhu Zhang · 2026 · Journal of Translational Medicine
The vicious cycle: unraveling the interplay between α-synuclein, mitochondrial dysfunction, and neuroinflammation in Parkinson’s disease
Yu-lin Liang, Feng-ge Yang, Qiang Tang · 2026 · Journal of Neurology
Mitochondria and brain aging: From cell-specific dysfunction to intercellular cooperation
Amandine Grimm, Undine Emmi Lang, Anne Eckert · 2026 · Neuron
The Choice of Leg During Pull Test in Parkinson's Disease: Not Mere Chance
Francesca Spagnolo, Augusto Maria Rini, Pietro Guida, Sara Longobardi, Petronilla Battista, Bruno Passarella · 2020 · Frontiers in Neurology
Prediction of submitochondrial proteins localization based on Gene Ontology
Jingyu Wang, Haihang Zhou, Yuxiang Wang, Mengdie Xu, Yun Yu, Junjie Wang, Yun Liu · 2023 · Computers in Biology and Medicine
Brain-Region-Specific Genes Form the Major Pathways Featuring Their Basic Functional Role: Their Implication in Animal Chronic Stress Model
Vladimir N. Babenko, Olga E. Redina, Дмитрий Александрович Смагин, Irina L. Kovalenko, Anna G. Galyamina, N. N. Kudryavtseva · 2024 · International Journal of Molecular Sciences
Activation of D2-like dopamine receptors improves the neuronal network and cognitive function of PPT1KI mice
Junqiang Zhao, Bingyan Feng, Zu-Cheng Ye, X. Ma, Jing-Zhi Du, Junmei Li, Wan-Liu Wu, Jingjing Gao, Song-Ji Li, Shiyong Peng et al. · 2024 · Acta Pharmacologica Sinica
Loss of function in Drosophila transcription factor Dif delays brain development in larvae resulting in aging adult brain
Ting Fang Tang, Jin Li, Bangwen Zhang, Liang Wen, Yuzhen Lu, Qihao Hu, Xiao‐Qiang Yu, Jie Zhang · 2024 · International Journal of Biological Macromolecules
HDAC4 /5 Inhibitor, LMK ‐235 Improves Animal Voluntary Movement in MPTP ‐Induced Parkinson's Disease Model
Heejin Lee, Hyun‐Jin Kim, Ju‐Sik Min, Eun Hye Lee, Dong Kyu Choi, Jae‐Hyeog Choi, Yohan Seo, Sion Lee, Chun Young Im, Gi Hun Bae et al. · 2025 · Pharmacology Research & Perspectives
α7‐Nicotinic Acetylcholine Receptor and Mutated α‐Synuclein Interact in Motor Behaviour and Nigrostriatal Dopamine—Findings With Potential Relevance for a Protective Effect of Cigarette Smoking and Parkinson's Disease
Christian Pifl, Alexandra Wolf, Mark Elevado, Petra Scholze · 2025 · European Journal of Neuroscience
Quantitative Strategies for Decoding Organelle Ion Dynamics
Palapuravan Anees · 2025 · ChemBioChem
PINK1 deficiency permits the development of Lewy body dementia with coexisting Aβ pathology
Tong‐Yao Gao, Xu‐Zheng Wang, Yuhan Xie, Tong Wang, Yun‐Bi Lu, Lu‐Long Huang, Cong Chen, Ming Zhang, Xin Ma, Yaling Chen et al. · 2025 · Alzheimer s & Dementia
CRISPR /Cas9‐Based Functional Genomics in Human Induced Pluripotent Stem Cell–Derived Models: Can “the Stars Align” for Neurodegenerative Diseases?
Yu Chen, Tiffany Jong, Chase Chen, Ellen Sidransky · 2022 · Movement Disorders
Saponin‐Encapsulated Microbubbles Protect Dopaminergic Neurons from MPTP‐Induced Oxidative Stress Injury
Zhuxia Zhang, Bingxuan Xu, Tao Lv, Yu Shi, Mengxin Wang, Die Hu, Azhen Hu, Ping Li, Shuping Lin, Shengwei Zhang et al. · 2023 · Advanced Therapeutics
Study of molecular patterns associated with ferroptosis in Parkinson’s disease and its immune signature
Lixia Chen, Guanghao Xin, Yijie He, Qinghua Tian, Xiaotong Kong, Yanchi Fu, Jianjian Wang, Huixue Zhang, Lihua Wang · 2023 · PLoS ONE
Neuroprotective Activity of Protocatechuic Acid (3,4-Dihydroxybenzoic Acid) to Treat Parkinson’s Disease
Jagatheesh Kaliaperumal, Satguru Dulari, Pandurangan A., Mahendra Singh Rathore, Amit Mittal, Md Shamshir Alam · 2020 · Journal of Evolution of Medical and Dental Sciences
A Peek into Parkinson’s Disease Progression through Human Dopamine Neurons in a Dish
Nan Yang, Zhenyu Yue · 2017 · Trends in Neurosciences
Does the Operation of Mitochondrial ATP-Dependent Potassium Channels Affect the Structural Component of Mitochondrial and Endothelial Dysfunctions in Experimental Parkinsonism?
A. A. Mosentsov, E. V. Rozova, Natalia V. Belosludtseva, I. N. Mankovskaya, Yu. V. Putiy, Karaban' In, I. B. Mikheeva, Galina D. Mironova · 2021 · Bulletin of Experimental Biology and Medicine
PINK1 Regulates Dopamine and Lipids at Mitochondria to Maintain Synapses and Neuronal Function
Christine Bus, Sven Geisler, Marita Pauline Feldkaemper, Hector Flores‐Romero, Anna Schaedler, Katharina I. Zittlau, Maria Zarani, Betül Uysal, Nicolas Casadei, Petra Fallier‐Becker et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
Gene-corrected Parkinson’s disease neurons show the A30P alpha-synuclein point mutation leads to reduced neuronal branching and function
Peter A. Barbuti, Bruno F. R. Santos, Paul M. A. Antony, François Massart, Gérald Cruciani, Claire Dording, Lukas Pavelka, Yong‐Jun Kwon, Rejko Krüger · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
DOPAL initiates αSynuclein-mediated impaired proteostasis in neuronal projections leading to enhanced vulnerability in Parkinson’s disease
Anna Masato, Nicoletta Plotegher, Andrea Thor, Stephen Adams, Michele Sandre, Susanna Cogo, Federica De Lazzari, Camilla Maria Fontana, Paul Anthony Martinez, Randy Strong et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
N-acetyl-l-leucine lowers pS129-synuclein and improves synaptic function in models of Parkinson’s disease
Pingping Song, Rossella Franchini, Chuyu Chen, Bryan Duong, Yizhi Wang, Jeffrey N. Savas, Loukia Parisiadou, Dimitri Krainc · 2025 · Research Square
Morphological profiling reveals neuroprotection via mitochondrial uncoupling in human dopaminergic neurons
Vyron A. Gorgogietas, Amélie Weiss, Loïc Cousin, David Hoffmann, Karen Schmitt, Arnaud Ogier, Peter A. Barbuti, Bruno F. R. Santos, Ibrahim Boussaad, Annika Wittich et al. · 2025 · Scientific Reports
Sleep deprivation and risk for Parkinson’s disease: evidence and therapeutic implications
Ting Zhou, Wujie Ye, Bingli Chen, Lu Zhu, Zhaoqin Wang, Jin-Feng Mao, Wenzhong Wu, Yi Li, Huangan Wu · 2025 · Journal of Neurology
Synergism of IP3R and Parkin mutants identifies mitochondrial stress as an early feature of Parkinson's disease
Mrudula Dileep, Anamika Sharma, Nandashree Kasturacharya, Syed Kavish Nizami, Steffy B. Manjila, Ashita Bhan, Gaiti Hasan · 2025 · Disease Models & Mechanisms
Dopamine neurotransmission in Parkinson's disease
Kaitlyn M.L. Cramb, Humaira Noor, Richard Wade-Martins, Stephanie J. Cragg · 2025 · Handbook of behavioral neuroscience
Loss of Nocturnin increases neuronal viability in oxidative stress conditions
Anne E. Ojo, Crystal Olivas-Rasmussen, Samuel S. Pappas, Carla B. Green · 2025 · Frontiers in Neuroscience
Dynamic redox monitoring in differentiated human neuroblastoma models of Parkinson’s disease
Jungeun Lim, Xavier Zhou, Srija Pamujula, Rukkia Liaqat, Ananya S. Achanta, Loren L. Looger, Benjamin C. Campbell, Melissa M. Campbell · 2025 · Redox Report
A biomaterial-cell model of inflammation-induced neurodegeneration of Parkinson’s disease
Yue Yu, Hongrui Xue, Hongyu Wang, Ye Fu, Yanshuang Zhang, Wenbo Yu, Lin Chen Yu, Jian Wang, Boxun Lu, Jiandong Ding · 2025 · Cell Biomaterials
Differentiation of human iPSCs into dopaminergic neurons: comparative analysis of 2D and 3D protocols for disease modeling and pharmacology
Giulia Sofia Marcotto, Jonida Bitraj, Emilio Merlo Pich, Ginetta Collo · 2026 · Neuroscience Applied
Bibliometric analysis of the pathogenesis of Parkinson's Disease
Yuan Feng, Kaixiao Wang, Xulong Guo, Huijie Guo, Xiaoya Gao · 2026 · Pathology - Research and Practice
Intranasal Conformal Patch for Sustained Levodopa Delivery and Reactive Oxygen Species Scavenging in Parkinson’s Disease
Ting Li, Lanxin Xiao, Zan Chen, Qiusui He, Rui Zhang, Haochen Zou, Bowen Yang, Xinyu Zhao, Qun‐Li Lei, Li Hua Gao et al. · 2026 · ACS Nano
Cell-autonomous and non-cell-autonomous drivers of dopamine neuron vulnerability in Parkinson’s disease
Alex Tchung, Amandine Even, Louis‐Éric Trudeau · 2026 · Trends in Neurosciences
Therapeutic potential of vagus nerve stimulation in neurodegenerative diseases: research progress and mechanisms
Qian Hu, Jiasheng Wang, Ruiyang Cao, Wenkai Liu, Lifeng Wang · 2026 · Frontiers in Immunology
Molecular mechanisms underlying Parkinson’s disease and role of phytochemicals, α-synuclein, sirtuins, and incretin mimetics in potential therapy
Sanjida Shahid Juthi, Prawej Ansari, Md Ferdos Ahmed, Joyeeta Tahseen Khan, Véronique Seidel, Sandeep Kumar, Reena Kumari, Aine M. McKillop, Yasser H.A. Abdel‐Wahab, Peter R. Flatt · 2026 · Frontiers in Pharmacology
DYRK1A and Parkinson’s disease, facts and hypotheses
Laurent Meijer, Mattias F. Lindberg, Gaëlle Hogrel, Bernard Khor · 2026 · Neurobiology of Disease
Role of the weak noncovalent interactions in the stability of the aggregated protonated dopamine in the aqueous solution: spectroscopic and quantum chemical calculation studies
Abhinanda Chowdhury, Prashant Chandra Singh · 2022 · Journal of Chemical Sciences
Monoamine Oxidase Inhibitor (MAO-I)-Mediated Neuroprotection for Treating Parkinson’s Disease
Toshiharu Nagatsu, Akira Nakashima · 2022 · Springer eBooks
Dopamine Homeostasis and Role of VMAT2 in Neurodegeneration
Eugene V. Mosharov · 2022 · Springer eBooks
Accurate Identification of Submitochondrial Protein Location Based on Deep Representation Learning Feature Fusion
Jianan Sui, Yuehui Chen, Yi Cao, Yaou Zhao · 2023 · Lecture notes in computer science
Taltirelin induces TH expression by regulating TRHR and RARα in medium spiny neurons
Kedong Zhu, Lanxia Meng, Jiaying Luo, Tingting Wen, Dan Liang, Zhihao Wang, Xuebing Cao, Zhaohui Zhang, Guiqin Chen · 2024 · Journal of Translational Medicine
Interactions between Oxidative Stress and Mitochondrial Dysfunction in Parkinson’s Disease: Potential of Natural Antioxidants
Yuqin Yue, Wenbi Jiang, Xuemei Wang, Zihao Tian, Yuanxu Cui, Xing Zhou · 2025 · Journal of Biosciences and Medicines
Activity-guided isolation of sesquiterpene coumarins from Ferula assa-foetida as monoamine oxidase inhibitors: Investigation on their therapeutic implications in a mice model of Parkinson's disease
Chayan Banerjee, Priyanka Yatham, Suchismita Mukherjee, Joy Chakraborty, Deepak Kumar · 2025 · Journal of Ethnopharmacology
Machine learning identifies lactate metabolism biomarkers and deciphers immune infiltration landscapes in Parkinson’s disease
Hongda Lv, LiNa Tan, Yiyi Miao, Yifan Zhou, Lingdian Wang, Zhanhua Liang · 2025 · Scientific Reports
Modification of Carbon Paste Electrode with Conductive Polyglycine-nafion Composite Membrane and Multi-wall Carbon Nanotubes for the Determination of Dopamine
Zhiqiang Wei, Runfang Liu, Dengyun Pan, Ting Li, Yuman Guo, Gaojie Ma, Hui Ying Yang, Sanqiang Li · 2019 · International Journal of Electrochemical Science
Determination of Dopamine Using Screen-printed Carbon Electrode Modified by PEDOT-MWCNTs double-layer Composites
Zhiqiang Wei, Yile Hu, Qingqing Tu, Shimeng Cui, Yiran Li, Yu Gan, Guilong Li, Hui Ying Yang, Sanqiang Li · 2021 · International Journal of Electrochemical Science
[Retracted] Synthesis, Characterization, and Specific Localization of Mitochondrial‐Targeted Antioxidant Peptide SS31 Probe
Yuan He, Ruixue Zhang, Zhuoya Quan, Beilei He, Yang Y. Xu, Zejun Chen, Yuan Ren, Xu Liu · 2021 · BioMed Research International · Retracted
Exploring a molecular switch for dopamine oxidation induced by charge reversal using scanning electrochemical microscopy
Yirong Xia, Wei Ni, Xiaorong Wang, Yougui Yu, Qing Zheng, Ximing Huang · 2021 · Journal of Electroanalytical Chemistry
Machine Learning Neuroprotective Strategy Reveals a Unique Set of Parkinson Therapeutic Nicotine Analogs
Felipe Rojas-Rodríguez, Carlos Morantes, Andrés Mauricio Pinzón, George Emilio Barreto, Ricardo Cabezas, Leonardo Mariño‐Ramírez, Janneth González · 2020 · The Open Bioinformatics Journal
Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia
Juan Antonio García-Carmona, Joaquín Amores-Iniesta, José Soler-Usero, M. Carmen Cerdán-Sánchez, Javier Navarro‐Zaragoza, María López-López, J.J. Soria-Torrecillas, Ainhoa Ballesteros-Arenas, José Antonio Pérez-Vicente, Pilar Almela · 2023 · Genes
Dopaminergic cell protection and alleviation of neuropsychiatric disease symptoms by VMAT2 expression through the class I HDAC inhibitor TC‐H 106
Heejin Lee, Hye‐Ji Kim, Dong Kyu Choi, Eun‐A Ko, Jae‐Hyeog Choi, Yohan Seo, Sion Lee, Soong‐Hyun Kim, Sejin Jung, Minwoo Kim et al. · 2023 · Pharmacology Research & Perspectives
Neurodegeneration caused by LRRK2-G2019S requires Rab10 in select dopaminergic neurons
Stavroula Petridi, C. Adam Middleton, Alison Fellgett, Laura Covill, Amy Stewart, Jack Munns, Friederike Elisabeth Kohrs, P. Robin Hiesinger, Laurence G. Wilson, Sangeeta Chawla et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
Deficiency in endocannabinoid synthase DAGLB contributes to Parkinson’s disease and dopaminergic neuron dysfunction
Zhenhua Liu, Nannan Yang, Jie Dong, Wotu Tian, Lisa Chang, Jinghong Ma, Jifeng Guo, Jieqiong Tan, Ao Dong, Kaikai He et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
DJ-1 depletion prevents immunoaging in T-cell compartments
Ningxiang Zeng, Christophe Capelle, Alejandra G Baron, Takumi Kobayashi, Séverine Ciré, Vera Tslaf, Catherine A. Leonard, Djalil Coowar, Hiroaki Koseki, Astrid Maria Westendorf et al. · 2022 · immuneACCESS
Diverging Parkinson’s Disease Pathology between patient-derived GBA N370S , LRRK2 G2019S and engineered SNCA A53T iPSC-derived Dopaminergic Neurons
Ali Fathi, Kiranmayee Bakshy, Lida Zieghami, Rebecca Fiene, Robert Bradley, Sarah Dickerson, Coby B. Carlson, Scott J. Schachtele, Jing Liu · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Preserved striatal innervation and motor function despite severe loss of nigral dopamine neurons following mitochondrial dysfunction induced by mtDNA mutations
Thomas Paß, Konrad M. Ricke, Pierre Hofmann, Roy Chowdhury, Yu Nie, Patrick Francis Chinnery, Heike Endepols, Bernd Neumaier, Andre Ferrer Carvalho, Lionel Rigoux et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Mitochondrial Function and Dysfunction in White Adipocytes and Therapeutic Implications
Fenfen Wang, Phu M. Huynh, Yu An · 2024 · Comprehensive physiology
Human in vitro disease models to aid pathway and target discovery for neurological disorders
Bhavana Muralidharan · 2021 · Elsevier eBooks
Dopamine Homeostasis and Role of VMAT2 in Neurodegeneration
Eugene V. Mosharov · 2021 · Springer eBooks